Steven McMahon, MD
Otolaryngology · Raleigh, NCNPI 1235131491
Payments from drug & device makers
Across 49 payments — averaging $30.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$345
- Sanofi$275
- Regeneron Healthcare Solutions, Inc.$186
- Medtronic$133
- Acclarent, Inc$130
- Myovant Sciences Inc.$118
- plus $291 from 11 others
What the payments were for
- Food & beverage$1,44498%
- Education$342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 14 | $345 |
| Sanofi | 8 | $275 |
| Regeneron Healthcare Solutions, Inc. | 6 | $186 |
| Medtronic | 2 | $133 |
| Acclarent, Inc | 2 | $130 |
| Myovant Sciences Inc. | 1 | $118 |
| Hikma Pharmaceuticals USA | 3 | $54 |
| Amgen | 2 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $48 |
| Intersect ENT, Inc. | 2 | $25 |
| Vertex | 1 | $23 |
| Davol Inc. | 1 | $19 |
| Stryker | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Merck | 1 | $15 |
| Novartis | 1 | $14 |
| Aerin Medical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,478 in reported general payments places this provider in the 60th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 68 | $2,252 |
| Fluticasone Propionate | 121 | $1,591 |
| Mometasone Furoate | 48 | $1,021 |
| Azelastine Hcl | 51 | $810 |
| Omeprazole | 48 | $746 |
| CefuroximeCefuroxime Axetil | 29 | $596 |
| Montelukast Sodium | 82 | $423 |
| Ofloxacin | 11 | $354 |
| Cefdinir | 16 | $301 |
| Doxycycline Monohydrate | 12 | $163 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $157 |
| Levocetirizine Dihydrochloride | 18 | $138 |
| Prednisone | 51 | $119 |
| Levofloxacin | 11 | $83 |
| Azithromycin | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Raleigh
- Robert FerrisRaleigh$2.5M
- Jeevan RamakrishnanRaleigh$12K
- Brett DorfmanRaleigh$6K
- Viraj PatelRaleigh$5K
- Nicolas George KatsantonisRaleigh$5K
- David JangDurham$1M
- Mark WeigelHuntersville$275K
- Stephen PottsWinston Salem$242K
- Adam ZanationHickory$227K
- Anne SelleckChapel Hill$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.